1. Home
  2. VYGR vs HWBK Comparison

VYGR vs HWBK Comparison

Compare VYGR & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.74

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$32.66

Market Cap

228.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
HWBK
Founded
2013
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
228.8M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
VYGR
HWBK
Price
$3.74
$32.66
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
862.4K
3.1K
Earning Date
03-09-2026
04-29-2026
Dividend Yield
N/A
2.58%
EPS Growth
N/A
31.42
EPS
N/A
3.43
Revenue
$10,135,000.00
N/A
Revenue This Year
$54.19
N/A
Revenue Next Year
$20.22
N/A
P/E Ratio
N/A
$9.50
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$25.50
52 Week High
$5.55
$36.25

Technical Indicators

Market Signals
Indicator
VYGR
HWBK
Relative Strength Index (RSI) 42.89 43.13
Support Level $3.36 $32.33
Resistance Level $3.74 $33.71
Average True Range (ATR) 0.32 0.87
MACD -0.06 -0.10
Stochastic Oscillator 4.87 12.89

Price Performance

Historical Comparison
VYGR
HWBK

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid-sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, checking, savings and money market accounts. The company also provides trust services including estate planning, investment and asset management services, brokerage and cash management services. Its primary source of revenue is net interest income derived from lending and deposit taking activities, with much of its business in commercial, commercial real estate development and residential mortgage lending.

Share on Social Networks: